Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clemastine fumarate 0.67mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clemastine fumarate 2.68 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clemastine fumarate and paracetamol and phenylpropanolamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clemastine fumarate 2.68 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 2.68 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
Has basis of strength substance (attribute) |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
Has basis of strength substance (attribute) |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
Has precise active ingredient |
False |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 2.68 mg oral tablet |
Has precise active ingredient |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate hydrochloride (substance) |
Is modification of (attribute) |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clemastine fumarate 134 microgram/mL oral solution |
Has precise active ingredient |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 134 microgram/mL oral solution |
Has basis of strength substance (attribute) |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clemastine fumarate 670 microgram and phenylpropanolamine 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely clemastine fumarate 670 microgram and phenylpropanolamine 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clemastine fumarate 1.34 mg oral tablet |
Has precise active ingredient |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 1.34 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet |
Has precise active ingredient |
True |
Clemastine fumarate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |